New Delhi: Exports of pharmaceutical and meditech sectors in India are expected to continue to grow despite global slowdown concerns, according to Arunish Chawla, Secretary, Department of Pharmaceuticals. With 16 blockbuster drugs in the pipeline — for cancer, diabetes, HIV and tuberculosis, the exports in these sectors have become the fourth-largest in the country in the last fiscal. Amid global slowdown concerns, the sector is experiencing double-digit growth, supported by government efforts and the Production Linked Incentive (PLI) scheme, the Secretary told reporters at the CII Pharma and Life Sciences summit. The 16 drugs to be produced in India are part of a larger list of 25 molecule
Hence then, the article about india s pharma meditech exports rise to 4th largest in fy25 despite global slowdown was published today ( ) and is available onNews room odisha ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( India’s pharma, meditech exports rise to 4th largest in FY25, despite global slowdown )